Skip to content

Is there a relationship between sensitivity to fat in the mouth and gastrointestinal tract, and is sensitivity to fat different in obesity?

A comparison of antropyloroduodenal motility, hormone release, appetite and energy intake after a 90 minute infusion of fat versus saline in lean and obese males

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000557235
Enrollment
20
Registered
2009-07-08
Start date
2009-02-02
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of the study was to investigate gastrointestinal and taste sensitivity to fats, and determine if 1) obese and lean individuals differed in their responses to an intraduodenal infusion of fat or saline and if their taste sensitivity to fats were also different, and 2) determine if taste and gastrointestinal fat sensitivity were related.

Interventions

Subjects received a 90 minute intraduodenal infusion of fat (C18:1) delivered at 0.78kcal per minute (70Kj total) and saline, at a rate of 2ml/ min (180ml total). Treatments were separated by 3-14 days, and all subjects received both treatments.

Sponsors

Christine Feinle-Bisset
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Subjects had to be males between the ages of 18 -55 years, with a body mass index (BMI) between 18 -35 kg/m2). Subjects were required to be unrestrained eaters, consume less than 20g of alcohol per week, be non-smokers, free of gastrointestinal or chronic disease and not currently taking medication whicfunction.

Exclusion criteria

Restrained eaters, smokers, sufferers of gastrointestinal or chronic disease, individuals currently on medication known to affect appetite or gastrointestinal function. Subjects completed factor 1 of the 3 factor eating questionnaire (restrained eaters are defined as those who score higher than 12), subjects were asked about their personal and familial medical history relating to chronic illness (heart disease and cancer) as well as gastrointestinal disease, ie Crohns, Irritable Bowel Syndrome. Subjects were asked if they were smokers, and how much alcohol they consumed on a weekly basis.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026